DPNCheck is a fast, accurate, and quantitative nerve conduction test that is used to evaluate nerves for evidence of peripheral neuropathy, such as diabetic peripheral neuropathy (DPN). It is designed to be used by clinicians at the point-of-care to objectively detect, stage, and monitor. The device measures nerve conduction velocity and response amplitude of the sural nerve, a nerve in the lower leg and ankle. These parameters are recognized as sensitive and specific biomarkers of peripheral neuropathy.

The ADVANCE System provides efficient and convenient nerve conduction studies at the point-of-care setting. ADVANCE allows physicians to immediately assess and a establish treatment plan for their patients. ADVANCE is used with proprietary nerve-specific electrode arrays for accuracy and standardization.

Quell is an advanced, non-invasive, nerve stimulation device that is covered by 18 U.S. utility patents. It is the only wearable neurostimulator that is enabled by a custom designed microchip that provides flexible, precise, high-power nerve stimulation in a form factor the size of a credit card. Quell utilizes position and motion sensing to automatically adjust stimulation for an optimal patient experience both day and night. The device supports Bluetooth^® low energy (BLE) to communicate with the Quell app, which is available for iOS and Android mobile devices.

The innovative Quell system is personalized to meet user needs and is smart enough to adjust therapy to changes during sleep and can even compensate for changes in the weather. Users have the option to personalize and manage their therapy discreetly via the Quell app, which offers therapy utilization, sleep, activity and pain tracking.